It has been demonstrated that the treatment of retinal endothelial cells with HG increased the release of IL-1β with a mechanism involving the activation of NF-kB, suggesting a role for IL-1β in the development of retinopathy in diabetes [54]. This evidence concerns the gene NFKB1 and diabetes mellitus.